Sinotau's Jiangsu branch is located in Wuxi New District. [Photo/WeChat account: xinwu_wx]

Sinotau's Jiangsu branch, located in Wuxi New District, was recently granted the first-ever Radioactive Drug Distribution License independently issued by the Jiangsu Provincial Medical Products Administration. This approval marks a significant milestone for the company, enabling the commercial distribution of radioactive pharmaceuticals.

Established in May 2023 with a registered capital of 30 million yuan ($4.23 million), Sinotau Jiangsu is the only subsidiary of the group focused on distributing radioactive drugs. The company manages the sales of all radioactive pharmaceuticals developed within the group and plans to distribute products from other well-known Chinese and international manufacturers.

Sinotau's Jiangsu branch in WND. [Photo/WeChat account: xinwu_wx]

In addition to fulfilling its internal needs for newly developed drugs, the company aims to provide efficient services for global radioactive pharmaceutical companies seeking entry into the Chinese market, further expanding its influence in the industry.